App-Quantinova.ai

Investigating astrocytes as mediators of tau spread

Matthew J Reid - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Progressive supranuclear palsy

N/A

Systematic Review of the Current Psychosocial Interventions for People with Moderate to Severe Dementia

Esther K Hui - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

An Investigation of HCV as a predictor of cognitive decline: the Bio-Hermes protocol

Robin Wolz - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Global Alzheimer’s Platform Foundation® (GAP) Development of a Transatlantic Alzheimer’s Disease Clinical Trial Network

Jason Bork - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

TNF inhibitors for the prevention of Alzheimer’s disease: Preliminary findings from the rheumatoid arthritis medication and memory study (RESIST)

Bethany McDowell - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Rheumatoid arthritis

N/A

Trial Readiness amongst EPAD Longitudinal Cohort Study Participants: Insights from the SPEAR study

Natassia F. Brenman - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

A data-driven disease progression model of fluid biomarkers in genetic FTD

Emma L. van der Ende - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Comparative analytical performance of multiple plasma Amyloid-beta assays and their relationship to amyloid PET

Stephen Zicha - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Disease progression models of familial frontotemporal lobar degeneration and the temporal ordering of biomarker changes in an international cohort

Adam L. Boxer - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

Enhancing Dementia Care during the Corona Pandemic: Zooming from Home

Nancy L Brown - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Dementia

N/A

Home monitoring of vital signs and generation of alerts in a cohort of people living with dementia

Michael David - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

Improvement in distinct cognitive functions between tablet PC and workbook in the SUPERBRAIN study

Jee Hyang Jeong - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

Endothelial dysfunction and cerebral small vessel disease in brains of older people

Atticus H Hainsworth - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cerebral small vessel disease

N/A

27-HYDROXYCHOLESTEROL PROMOTES OLIGODENDROCYTIC MATURATION – IMPLICATIONS FOR ALZHEIMER’S DISEASE

Vilma Alanko - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Left ventricular hypertrophy and incident cognitive impairment in elderly hypertensive patients: Hypertension in the Very Elderly Trial

Ying Xu - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular hypertrophy

N/A

The experiences of apathy in people with dementia and mild cognitive impairment and their carers: a qualitative interview study.

Clare Burgon - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Evaluating the relationship between soluble triggering receptor expressed on myeloid cells 2 (sTREM2) and pathological substrates of Alzheimer’s Disease (AD).

Malak Wahdan - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

AV-1451

Complement and NfL associations with brain structure and functional connectivity alterations in presymptomatic and symptomatic GRN mutation carriers

Taru M. Flagan - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

Progranulin

IgA Nephropathy associated with Psoriasis and Lymphoma

saad ahmed - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Focal segmental glomerulosclerosis

Bendamustine

Inside ANEMIA of CKD: microsimulation modeling of the epidemiological burden of anemia of CKD in the USA

Lise Retat - National Kidney Foundation (NKF) , 2021

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Renal anemia

N/A

Filters

45280 Abstracts